Prognostic factors for the efficacy of silodosin in the treatment of symptomatic benign prostatic hyperplasia. Subanalysis of the URAL study

1. Salinas-Casa, J.
2. Vírseda-Chamorro, M.
3. Méndez-Rubio, S.
4. Luján Galán, M.
5. Esteban-Fuertes, M.
6. Moreno-Sierra, J.